154 related articles for article (PubMed ID: 31538930)
1. Case Studies and Literature Review of Pneumococcal Septic Arthritis in Adults.
Dernoncourt A; El Samad Y; Schmidt J; Emond JP; Gouraud C; Brocard A; El Hamri M; Plassart C; Rousseau F; Salle V; Diouf M; Varon E; Hamdad F
Emerg Infect Dis; 2019 Oct; 25(10):1824-33. PubMed ID: 31538930
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal septic arthritis in adults: clinical analysis and review.
Belkhir L; Rodriguez-Villalobos H; Vandercam B; Marot JC; Cornu O; Lambert M; Yombi JC
Acta Clin Belg; 2014; 69(1):40-6. PubMed ID: 24635398
[TBL] [Abstract][Full Text] [Related]
3.
Hyams C; Amin-Chowdhury Z; Fry NK; North P; Finn A; Judge A; Ladhani SN; Williams OM
Emerg Microbes Infect; 2021 Dec; 10(1):1369-1377. PubMed ID: 34151740
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal septic arthritis: review of 190 cases.
Ross JJ; Saltzman CL; Carling P; Shapiro DS
Clin Infect Dis; 2003 Feb; 36(3):319-27. PubMed ID: 12539074
[TBL] [Abstract][Full Text] [Related]
5. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era.
Olarte L; Romero J; Barson W; Bradley J; Lin PL; Givner L; Tan T; Hoffman J; Hultén KG; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2017 Dec; 36(12):1201-1204. PubMed ID: 28723870
[TBL] [Abstract][Full Text] [Related]
6. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
7. [Pneumococcal septic arthritis in a Spanish university hospital (1993- 2003)].
Barahona L; Soriano F; Fernández-Robles R; Granizo JJ; López-Durán JC
Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):22-4. PubMed ID: 15701329
[TBL] [Abstract][Full Text] [Related]
8. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
9. Isolated septic arthritis caused by penicillin-resistant Streptococcus pneumoniae.
Lane JE; Moore CC; Beckish ML; Stephens JL
South Med J; 2001 Apr; 94(4):429-31. PubMed ID: 11332912
[TBL] [Abstract][Full Text] [Related]
10. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
Brandileone MC; Almeida SCG; Minamisava R; Andrade AL
Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pneumoniae septic arthritis in adults.
James PA; Thomas MG
Scand J Infect Dis; 2000; 32(5):491-4. PubMed ID: 11055652
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal serotype evolution in Western Europe.
Tin Tin Htar M; Christopoulou D; Schmitt HJ
BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
[TBL] [Abstract][Full Text] [Related]
14. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM
J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine.
Medeiros MIC; Almeida SCG; Guerra MLLS; da Silva P; Carneiro AMM; de Andrade D
BMC Infect Dis; 2017 Aug; 17(1):590. PubMed ID: 28841854
[TBL] [Abstract][Full Text] [Related]
16. Rates of, and risk factors for, septic arthritis in patients with invasive pneumococcal disease: prospective cohort study.
Marrie TJ; Tyrrell GJ; Majumdar SR; Eurich DT
BMC Infect Dis; 2017 Oct; 17(1):680. PubMed ID: 29025402
[TBL] [Abstract][Full Text] [Related]
17. Septic arthritis due to Streptococcus pneumoniae in Nottingham, United Kingdom, 1985-1998.
Ispahani P; Weston VC; Turner DP; Donald FE
Clin Infect Dis; 1999 Dec; 29(6):1450-4. PubMed ID: 10585794
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG;
JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of serotypes causing invasive pneumococcal disease in the region of Tarragona, Spain, 2006-2009: vaccine-serotype coverage for the distinct antipneumococcal vaccine formulations].
Ochoa-Gondar O; Gómez-Bertomeu F; Vila-Córcoles A; Raga X; Aguirre C; Utrera J; de Diego C; Guzmán JA; Figuerola E;
Rev Esp Quimioter; 2015 Feb; 28(1):29-35. PubMed ID: 25690142
[TBL] [Abstract][Full Text] [Related]
20. Serotype prevalence of occult pneumococcal bacteremia.
Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]